ストックスクリーナーアプリを入手
5.135
0.81%
0.045
前日終値:
$5.09
開ける：
$5.12
24時間の取引高:
241.69K
Relative Volume:
0.30
時価総額：
$409.49M
収益：
$116.30M
当期純損益:
$17.73M
株価収益率:
24.45
EPS:
0.21
ネットキャッシュフロー:
$20.88M
1週間 パフォーマンス:
-1.33%
1か月 パフォーマンス:
-21.06%
6か月 パフォーマンス:
-49.30%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$5.03
$5.14
1週間の範囲:
$4.925
$5.31
52週間の値動き範囲:
$4.925
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Compare NAGE vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
5.131 | 406.21M | 116.30M | 17.73M | 20.88M | 0.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
495.31 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.80 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
837.03 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.52 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
349.42 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-27 | 開始されました | Canaccord Genuity | Buy |
| 2022-08-16 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-08-11 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 開始されました | ROTH Capital | Buy |
| 2019-10-16 | 開始されました | Oppenheimer | Outperform |
| 2019-02-14 | 開始されました | B. Riley FBR | Buy |
| 2017-11-27 | 再開されました | H.C. Wainwright | Buy |
| 2017-09-25 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-01-03 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Niagen Bioscience Inc (NAGE) 最新ニュース
Is Niagen Bioscience Inc. a cyclical or defensive stockEarnings Beat & Real-Time Buy Signal Alerts - mfd.ru
Can Niagen Bioscience Inc be recession proofJuly 2025 Drop Watch & Accurate Buy Signal Notifications - baoquankhu1.vn
Does BNTX outperform in volatile marketsJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - baoquankhu1.vn
Niagen Bioscience Sponsors Inaugural NAD for Health Conference - intellectia.ai
Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Conference Hosted by the University of Copenhagen - Business Wire
Does Niagen Bioscience (NAGE) Still Hold a Defensible NAD+ Moat Ahead of Its 2025 Earnings Call? - simplywall.st
Niagen’s NAD+ Bet Is Paying Off, But The Price Is Steep - Finimize
Niagen Bioscience to Host Q4 and FY 2025 Earnings Call - Intellectia AI
Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026 - Business Wire
Institutional Owners May Consider Drastic Measures as Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Recent US$69m Drop Adds to Long-term Losses - 富途牛牛
A Look At Niagen Bioscience (NAGE) Valuation As New Partner Launches And Clinical Data Gain Attention - Sahm
How is Niagen Bioscience Inc. managing supply chain issuesInflation Watch & Fast Moving Market Watchlists - baoquankhu1.vn
Assessing Niagen Bioscience (NAGE) Valuation As NAD+ IP And Upcoming Clinical Data Draw Renewed Attention - Yahoo Finance
Niagen Bioscience, Inc. (NAGE): A Bull Case Theory - Finviz
Niagen Bioscience Boosts TRU NIAGEN Sales on Amazon and Online - RS Web Solutions
How Investors Are Reacting To Niagen Bioscience (NAGE) Expanding TRU NIAGEN Distribution Through Amazon And E-Commerce - Yahoo Finance
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Promising Upside with a 163.77% Potential - DirectorsTalk Interviews
Earnings Beat: Is now the right time to enter Niagen Bioscience Inc2025 Biggest Moves & Real-Time Buy Zone Alerts - baoquankhu1.vn
Aug PreEarnings: Can GPJA weather a recessionGlobal Markets & Entry Point Strategy Guides - baoquankhu1.vn
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Published on: 2026-01-30 06:37:48 - baoquankhu1.vn
Niagen Bioscience (NASDAQ:NAGE) Shares Down 3.4%Here's What Happened - MarketBeat
Niagen Bioscience (NASDAQ:NAGE) Shares Down 3.4% – Here’s What Happened - Defense World
Assessing Niagen Bioscience (NAGE) Valuation After New Truemed HSA And FSA Partnership - Sahm
Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a 151% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Published on: 2026-01-20 17:04:22 - baoquankhu1.vn
Will Niagen Bioscience Inc outperform its industry peers2025 Price Action Summary & Growth Focused Entry Reports - baoquankhu1.vn
Exit Recap: What is the Moat Score of Niagen Bioscience IncBond Market & Community Consensus Stock Picks - baoquankhu1.vn
Can Niagen Bioscience’s (NAGE) HSA Access Shift Redefine Its Direct-to-Consumer Growth Strategy? - Yahoo Finance
Revenue Check: Is now the right time to enter Niagen Bioscience IncTrade Exit Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
A Look At Niagen Bioscience (NAGE) Valuation After New HSA And FSA Purchasing Option For Tru Niagen - Sahm
Niagen Bioscience now allows HSA/FSA payments for Tru Niagen By Investing.com - Investing.com Nigeria
NAGE: Niagen Bioscience advances NAD health solutions, expanding into IV, telehealth, and skincare - TradingView — Track All Markets
Niagen Bioscience (NAGE) Valuation In Focus As Investor Summit Appearance Nears - Yahoo Finance
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S. - morningsun.net
Niagen Bioscience now allows HSA/FSA payments for Tru Niagen - Investing.com
Is Niagen Bioscience (NAGE) Using Investor Summits To Recast Its Healthy Aging Strategy Narrative? - simplywall.st
Insider Buy: Whats the beta of Niagen Bioscience Inc stockEarnings Growth Summary & Fast Momentum Entry Tips - baoquankhu1.vn
Will Weakness in Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Stock Prove Temporary Given Strong Fundamentals? - Yahoo Finance
Is Niagen Bioscience Inc. stock resilient to inflationMarket Growth Report & Entry and Exit Point Strategies - Улправда
Niagen Bioscience, Inc. (NAGE) Stock Analysis: 140.85% Upside Potential Captures Investor Attention - DirectorsTalk Interviews
Published on: 2026-01-08 21:02:30 - Улправда
Will Niagen Bioscience Inc. stock benefit from sector rotationWeekly Profit Report & Fast Momentum Stock Entry Tips - ulpravda.ru
Will Niagen Bioscience Inc. stock deliver shareholder valueJuly 2025 Momentum & Consistent Return Strategy Ideas - ulpravda.ru
Why Niagen Bioscience Inc. stock attracts global investorsJuly 2025 Gainers & Smart Swing Trading Alerts - Улправда
Published on: 2026-01-09 00:19:58 - Улправда
Should I hold or sell Niagen Bioscience Inc. stock in 20252025 Bull vs Bear & Weekly High Potential Alerts - ulpravda.ru
Niagen Bioscience: Why Discipline Matters In A Crowded Supplement Market (NASDAQ:NAGE) - Seeking Alpha
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Niagen Bioscience Inc (NAGE) 財務データ
収益
当期純利益
現金流量
EPS
0.49%
2.23%
大文字化:
|
ボリューム (24 時間):